Table 1.

Patients’ characteristics

	Colorectal cancer	Pancreatic cancer
N	11	9
Male/female	7/4	8/1
Age, mean (range)	63 (55–73)	67 (48–82)
Stage at study entry	Stage IV	Stage IV
Microsatellite status at study entry	MSS	MSS
Prior lines of systemic treatment, mean (range)	5 (2–9)	3 (1–5)
Patients with prior surgery (number of surgeries)	4 (1–7)	2 (1–3)
Best response last treatment	PD (10), SD (1)	PD (9)
Time since last systemic prior treatment (mean)	2 months	1.5 months

MSS, Microsatellite stable; PD, Progressive disease; SD, Stable disease.